Timing of end-of-life discussions for patients with blood cancers
12/21/2015
A majority of hematologic oncologists report that end-of-life (EOL) discussions happen with patients with blood cancers too late, according to an article published online by JAMA Internal Medicine.
Afatinib a better choice for EGFR-mutated lung cancer in first-line treatment
12/21/2015
Patients with EGFR-activating mutations in advanced lung cancer seem to benefit more from afatinib than gefitinib as first-line treatment, researchers report at the first ESMO Asia 2015 Congress in...
A new study has found immunotherapy to be more effective than chemotherapy in treating most previously treated patients with advanced lung cancer, and demonstrated effectiveness in a wider...
New tool for detecting and measuring aggressiveness of prostate cancer
12/21/2015
Scientists claim method is potentially more accurate than PSA and could minimize predicament of over-diagnosis at screening.
European Commission approves Amgen's IMLYGIC as first oncolytic immunotherapy in Europe
12/21/2015
Amgen has announced that the European Commission has approved the use of IMLYGIC™ (talimogene laherparepvec) for the treatment of adults with unresectable melanoma that is regionally or...
When cancer of unknown origin strikes, family members are at increased risk
12/21/2015
Cancer usually begins in one location and then spreads, but in 3-5% of cancer patients, the tissue where a cancer began is unknown.
Immunotherapy and targeted therapy provide new options for difficult-to-treat head and neck cancer
12/21/2015
Phase I trial reports that pembrolizumab is active in nasopharyngeal cancer.Afatinib is effective as second-line treatment in squamous cell carcinoma of the head and neck in a Phase II study.
FDA propose to ban use of tanning beds by under-18s
12/21/2015
The US regulator is proposing to restrict the use of sunlamp products to adults aged 18 and over as a safety measure to cut rates of eye injury, skin damage and skin cancer.
New model for vascular and tumor research
12/21/2015
VOGIM cell culture technique allows tumor growth to be observed. Two characteristic features of malignant tumours are that they form massive blood vessels and bypass the immune system.
Blood cell count at bedside steps closer with new biochip
12/21/2015
Complete blood cell counts - the most commonly ordered blood test - currently have to be done in expensive labs. Now, a new biochip could bring the test to the bedside.